334 related articles for article (PubMed ID: 36890458)
1. Endothelial dysfunction due to eNOS uncoupling: molecular mechanisms as potential therapeutic targets.
Janaszak-Jasiecka A; Płoska A; Wierońska JM; Dobrucki LW; Kalinowski L
Cell Mol Biol Lett; 2023 Mar; 28(1):21. PubMed ID: 36890458
[TBL] [Abstract][Full Text] [Related]
2. Role of BH
DuBose LE; Ozemek C; Wick T; Richardson V; Hildreth KL; Moreau KL
Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H975-H982. PubMed ID: 36149770
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle-mediated delivery of tetrahydrobiopterin restores endothelial function in diabetic rats.
Kelly KA; Heaps CL; Wu G; Labhasetwar V; Meininger CJ
Nitric Oxide; 2024 Jul; 148():13-22. PubMed ID: 38642795
[TBL] [Abstract][Full Text] [Related]
4. Supplementation with Phycocyanobilin, Citrulline, Taurine, and Supranutritional Doses of Folic Acid and Biotin-Potential for Preventing or Slowing the Progression of Diabetic Complications.
McCarty MF
Healthcare (Basel); 2017 Mar; 5(1):. PubMed ID: 28335416
[TBL] [Abstract][Full Text] [Related]
5. Novel strategies to ameliorate radiation injury: a possible role for tetrahydrobiopterin.
Berbée M; Fu Q; Kumar KS; Hauer-Jensen M
Curr Drug Targets; 2010 Nov; 11(11):1366-74. PubMed ID: 20583982
[TBL] [Abstract][Full Text] [Related]
6. Role of the eNOS Uncoupling and the Nitric Oxide Metabolic Pathway in the Pathogenesis of Autoimmune Rheumatic Diseases.
Łuczak A; Madej M; Kasprzyk A; Doroszko A
Oxid Med Cell Longev; 2020; 2020():1417981. PubMed ID: 32351667
[TBL] [Abstract][Full Text] [Related]
7. Tetrahydrobiopterin in cardiovascular health and disease.
Bendall JK; Douglas G; McNeill E; Channon KM; Crabtree MJ
Antioxid Redox Signal; 2014 Jun; 20(18):3040-77. PubMed ID: 24294830
[TBL] [Abstract][Full Text] [Related]
8. Unravelling the Intricate Relationship Between Oxidative Stress and Endothelial Dysfunction in Hypertension.
Sharma A; Patil SM; Dasgupta A; Podder A; Kumar J; Sindwani P; Karumuri P
Cureus; 2024 May; 16(5):e61245. PubMed ID: 38939274
[TBL] [Abstract][Full Text] [Related]
9. Retraction. Fenofibrate improves the impaired endothelial progenitor cell function through inhibiting eNOS uncoupling in diabetic mice.
Zhao T; Deng YP; Ni M; Chen JK; Li ZP; Li DJ; Shen FM
Br J Pharmacol; 2015 Dec; 172(23):5704-28. PubMed ID: 25537824
[TBL] [Abstract][Full Text] [Related]
10. A multicentric consortium study demonstrates that dimethylarginine dimethylaminohydrolase 2 is not a dimethylarginine dimethylaminohydrolase.
Ragavan VN; Nair PC; Jarzebska N; Angom RS; Ruta L; Bianconi E; Grottelli S; Tararova ND; Ryazanskiy D; Lentz SR; Tommasi S; Martens-Lobenhoffer J; Suzuki-Yamamoto T; Kimoto M; Rubets E; Chau S; Chen Y; Hu X; Bernhardt N; Spieth PM; Weiss N; Bornstein SR; Mukhopadhyay D; Bode-Böger SM; Maas R; Wang Y; Macchiarulo A; Mangoni AA; Cellini B; Rodionov RN
Nat Commun; 2023 Jun; 14(1):3392. PubMed ID: 37296100
[TBL] [Abstract][Full Text] [Related]
11. The effect of exenatide (a GLP-1 analogue) and sitagliptin (a DPP-4 inhibitor) on asymmetric dimethylarginine (ADMA) metabolism and selected biomarkers of cardiac fibrosis in rats with fructose-induced metabolic syndrome.
Wójcicka G; Pradiuch A; Fornal E; Stachniuk A; Korolczuk A; Marzec-Kotarska B; Nikolaichuk H; Czechowska G; Kozub A; Trzpil A; Góralczyk A; Bełtowski J
Biochem Pharmacol; 2023 Aug; 214():115637. PubMed ID: 37290595
[TBL] [Abstract][Full Text] [Related]
12. Plasma asymmetric dimethylarginine is associated with vulnerable plaque and long-term outcomes in stable coronary artery disease.
Huang SS; Huang WC; Tsai CT; Chen YY; Lee SH; Lu TM
Sci Rep; 2023 May; 13(1):7541. PubMed ID: 37160906
[TBL] [Abstract][Full Text] [Related]
13. Role of ADMA in the pathogenesis of microvascular complications in type 2 diabetes mellitus.
Guo X; Xing Y; Jin W
Front Endocrinol (Lausanne); 2023; 14():1183586. PubMed ID: 37152974
[TBL] [Abstract][Full Text] [Related]
14. The Nitrate-Nitrite-Nitric Oxide Pathway: Potential Role in Mitigating Oxidative Stress in Hypertensive Disorders of Pregnancy.
Barbosa PO; Tanus-Santos JE; Cavalli RC; Bengtsson T; Montenegro MF; Sandrim VC
Nutrients; 2024 May; 16(10):. PubMed ID: 38794713
[TBL] [Abstract][Full Text] [Related]
15. Innovative Treatments to Counteract Endothelial Dysfunction in Chronic Kidney Disease Patients.
Marrone G; Cornali K; Di Lauro M; Ceravolo MJ; Di Marco L; Manca di Villahermosa S; Mitterhofer AP; Noce A
Biomedicines; 2024 May; 12(5):. PubMed ID: 38791047
[TBL] [Abstract][Full Text] [Related]
16. Modulating Nitric Oxide: Implications for Cytotoxicity and Cytoprotection.
Belenichev I; Popazova O; Bukhtiyarova N; Savchenko D; Oksenych V; Kamyshnyi O
Antioxidants (Basel); 2024 Apr; 13(5):. PubMed ID: 38790609
[TBL] [Abstract][Full Text] [Related]
17. miR-486-5p protects against rat ischemic kidney injury and prevents the transition to chronic kidney disease and vascular dysfunction.
Douvris A; Viñas JL; Gutsol A; Zimpelmann J; Burger D; Burns KD
Clin Sci (Lond); 2024 May; 138(10):599-614. PubMed ID: 38739452
[TBL] [Abstract][Full Text] [Related]
18. Aging in Ocular Blood Vessels: Molecular Insights and the Role of Oxidative Stress.
Cui X; Buonfiglio F; Pfeiffer N; Gericke A
Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672172
[TBL] [Abstract][Full Text] [Related]
19. Oral nitrate-reducing bacteria as potential probiotics for blood pressure homeostasis.
Chai X; Liu L; Chen F
Front Cardiovasc Med; 2024; 11():1337281. PubMed ID: 38638884
[TBL] [Abstract][Full Text] [Related]
20. Recent progresses in gut microbiome mediates obstructive sleep apnea-induced cardiovascular diseases.
Zhang X; Zhang H; Li S; Fang F; Yin Y; Wang Q
FASEB Bioadv; 2024 Apr; 6(4):118-130. PubMed ID: 38585431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
